BCR and Familial prostate cancer: They found a significant decrease in BCR‐free survival for AA men as compared to CA men on univariable analysis, but not after adjustment for multiple covariates; no difference in aggressive PSA recurrence, metastasis‐free survival, prostate cancer‐specific survival, or overall death for AA men compared to CA men were observed.